Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Ronalds Macuks"'
Autor:
Rosanna Mancari, Yildirim Yusuf, Ronalds Macuks, Patriciu Achimas-Cadariu, Jurgen Martinus Piek, Isabella Sperduti, Giacomo Corrado, Enrico Vizza, Ignacio Zapardiel
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectiveThe purpose of the study was to analyse the role of prognostic factors on the risk of recurrence and overall survival of patients with uterine adenosarcoma.MethodsA retrospective international multicentre study involving 46 centres collected
Externí odkaz:
https://doaj.org/article/46f502115910403c933c7e7f02e232b0
Autor:
Myriam Gracia, Yusuf Yildirim, Ronalds Macuks, Rosanna Mancari, Patriciu Achimas-Cadariu, Stephan Polterauer, Sara Iacoponi, Ignacio Zapardiel
Publikováno v:
Cancers, Vol 15, Iss 5, p 1463 (2023)
Background: The aim of this study was to assess the impact of prognostic factors on the survival of patients diagnosed with uterine carcinosarcoma. Methods: A sub-analysis of the SARCUT study, a multicentric retrospective European study, was carried
Externí odkaz:
https://doaj.org/article/e2279364e6ba4378b7a816c6d603c9fb
Autor:
Pluvio J. Coronado, Maria Alonso-Espias, Yusuf Yildirim, Ronalds Macuks, Rosanna Mancari, Patriciu Achimas-Cadariu, Silvana M. Aniorte, Marco Mitidieri, Eric Lambaudie, Nathanael Dubois, Ignacio Zapardiel
Publikováno v:
Gynecologic Oncology. 174:28-33
Autor:
Ignacio Zapardiel, Myriam Gracia Segovia, Ronalds Macuks, Rosanna Mancari, Patriciu Achimas-Cadariu, Giacomo Corrado, Arnoldas Bartusevicius, Vladyslav Sukhin, Juan C Muruzabal, Pluvio J Coronado Martín, Barbara Gardella, Jurgen M Piek, Nicole Concin, Clemente Arab, Dimitrios Papatheodorou, Stephan Polterauer, Sara Iacoponi, Teresa Nieto, Martha C Lopez-Sanclemente, Hanna Trukhan, Maria M Gil, Irina Bakinovskaya, Alena Dalamanava, Marc Cucurull, Dzmitry Rovski, Laura Baquedano, Luis Chiva, Marcin Mardas, Siarhei Anatolievich Mavrichev, Jaroslav Klat, Carlos A Lopez de la Manzanara, Yusuf Yildirim
Publikováno v:
International Journal of Gynecologic Cancer. :ijgc-2022
ObjectiveUterine sarcomas are a rare and heterogeneous group of malignancies that include different histological sub-types. The aim of this study was to identify and evaluate the impact of the different prognostic factors on overall survival and dise
Autor:
Natascha de Lange, Ratko Delić, Natasha Nikolova, Rosa Maria Alvarez, Irina Gagua, İlker Selçuk, Sara Nasser, Piotr Lepka, Kamil Zalewski, Elko Gliozheni, M Hruda, Linnea Ekdahl, Claudia Andrade, Catarina Pardal, Zoia Razumova, Tanja Nikolova, Delphine Hudry, Sofie Leisby Antonsen, Vladyslav Sukhin, Dimitrios-Efthymios Vlachos, Szabolcs Molnár, Mir Fuad Hasanov, Alima Satanova, Ronalds Macuks, Rosa Montero-Macías, Nicolò Bizzarri, Ilker Kahramanoglu, Maximilian Lanner, Ane Gerda Zahl Eriksson, Filip Fruhauf, Rasiah Bharathan, Sileny Han, Charlampos Theofanakis, Bojana Gutic, Liidia Gristsenko, Nina Kovacevic, Jelena Dotlic, Suzanna Babloyan, Ramina Karimbayli, Andrei Pletnev
Publikováno v:
International Journal of Gynecological Cancer, 31(4), 575-584. LIPPINCOTT WILLIAMS & WILKINS
BackgroundESGO (European Society of Gynaecological Oncology) and partners are continually improving the developmental opportunities for gynaecological oncology fellows. The objectives of this survey were to evaluate the progress in the infrastructure
Autor:
Ignacio, Zapardiel, Sara, Iacoponi, Pluvio J, Coronado, Kamil, Zalewski, Frank, Chen, Christina, Fotopoulou, Polat, Dursun, Ioannis C, Kotsopoulos, Robert, Jach, Alessandro, Buda, Maria J, Martinez-Serrano, Christoph, Grimm, Robert, Fruscio, Enrique, Garcia, Jacek Jan, Sznurkowski, Cristina, Ruiz, Maria C, Noya, Dib, Barazi, Javier, Diez, Begoña, Diaz De la Noval, Arnoldas, Bartusevicius, Pierandrea, De Iaco, Maria, Otero, Maria, Diaz, Dimitrios, Haidopoulos, Silvia, Franco, Pawel, Blecharz, Miguel A, Zuñiga, Patricia, Rubio, Barbara, Gardella, Dimitrios C, Papatheodorou, Yusuf, Yildirim, Francesc, Fargas, Ronalds, Macuks, P, Vieira-Baptista
ObjectiveThis study aimed to analyze the prognostic factors for overall and progression-free survival in patients with vulvar cancer.MethodsThis international, multicenter, retrospective study included 2453 patients diagnosed with vulvar cancer at 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6426e3cc2cc774b59b2601c7afd6762
http://hdl.handle.net/11585/808392
http://hdl.handle.net/11585/808392
Autor:
Sara Iacoponi, Ignacio Zapardiel, Kamil Zalewski, Christoph Grimm, Stephan Polterauer, Ronalds Macuks, Richard Schwameis
Publikováno v:
Gynecologic Oncology. 147:92-97
To estimate the prognostic significance of lymph node ratio and number of positive nodes in vulvar cancer patients.This international multicenter retrospective study included patients diagnosed with vulvar cancer treated with inguinal lymphadenectomy
Utility Serum Marker HE4 for the Differential Diagnosis Between Endometriosis and Adnexal Malignancy
Autor:
Ignacio Zapardiel, Margarida Silveira, Ronalds Macuks, Maria T. Allende, Mikel Gorostidi, Antonella Ravaggi, Daniel Abehsera
Publikováno v:
International Journal of Gynecologic Cancer. 26:52-55
ObjectiveThe aim of the study was to assess the utility of serum human epididymal secretory protein E4 (HE4) biomarker in the differential diagnosis of endometriosis and adnexal malignancies.MethodsMulticentric prospective observational study between
Publikováno v:
International Journal of Reproduction, Contraception, Obstetrics and Gynecology. :3789-3794
Background: The aim of the study is to evaluate the cervical cancer screening programme in Latvia and to determine how early cervical cancer diagnostics can be improved and the burden of the disease can be reduced. Methods: All cervical cancer cases
Autor:
Margarida Silveira, Ronalds Macuks, Maria T. Allende, Antonella Ravaggi, Mikel Gorostidi, Ignacio Zapardiel
Publikováno v:
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 26(4)
The aim of this study was to assess the usefulness of the human epididymis protein 4 (HE4) serum biomarker in predicting malignant disease in a clinical setting in comparison with other diagnostic tools, such as serum CA125 and ROMA score. A multicen